Carlos Medina-Perez1, Fernanda de Souza-Teixeira2, Rodrigo Fernandez-Gonzalo3, Jose Antonio de Paz-Fernandez1. 1. Institute of Biomedicine (IBIOMED), University of Leon, León, Spain. 2. School of Physical Education, Department of Physical Education and Health, Federal University of Pelotas, Pelotas/rs, Brazil. 3. Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Abstract
BACKGROUND: Although resistance training adaptations in multiple sclerosis (MS) patients have been described, the detraining response in this population is largely unknown. OBJECTIVE: [corrected] This study was designed to evaluate the effects of a 12-week detraining period on muscle strength (isometric and endurance) and muscle power of multiple sclerosis (MS) patients that had previously carried out a 12-weekresistance training program (RTP). METHODS:Forty-two MS patients were randomly assigned into two groups: an exercise group (EG) that performed a 12-week RTP for the knee extensors muscles; and a control group (CG), that did not perform any specific training. Knee extension maximal voluntary isometric contraction (MVIC), muscle power and muscle endurance were evaluated before and after the RTP, as well as 12 weeks after training completion. A strain gauge was used to measure the maximal voluntary isometric contraction and muscle power was assessed with a linear encoder. Muscle endurance was interpreted as the number of repetitions that a patient could perform in a single set of knee extension exercise. RESULTS: The EG increased MVIC and muscle power after the training period, although the training did not affect muscle endurance. After 12 weeks of detraining, MVIC returned to pre-training values but muscle power was still greater than pre-training values in the EG. The CG did not present any change in the variables measured during the intervention. CONCLUSIONS: A 12-week RTP improved MVIC and muscle power in MS patients. Additionally, 12 weeks of detraining blunted strength training adaptations in MS patients, although muscle power training adaptations were still evident after the detraining period.
RCT Entities:
BACKGROUND: Although resistance training adaptations in multiple sclerosis (MS) patients have been described, the detraining response in this population is largely unknown. OBJECTIVE: [corrected] This study was designed to evaluate the effects of a 12-week detraining period on muscle strength (isometric and endurance) and muscle power of multiple sclerosis (MS) patients that had previously carried out a 12-week resistance training program (RTP). METHODS: Forty-two MSpatients were randomly assigned into two groups: an exercise group (EG) that performed a 12-week RTP for the knee extensors muscles; and a control group (CG), that did not perform any specific training. Knee extension maximal voluntary isometric contraction (MVIC), muscle power and muscle endurance were evaluated before and after the RTP, as well as 12 weeks after training completion. A strain gauge was used to measure the maximal voluntary isometric contraction and muscle power was assessed with a linear encoder. Muscle endurance was interpreted as the number of repetitions that a patient could perform in a single set of knee extension exercise. RESULTS: The EG increased MVIC and muscle power after the training period, although the training did not affect muscle endurance. After 12 weeks of detraining, MVIC returned to pre-training values but muscle power was still greater than pre-training values in the EG. The CG did not present any change in the variables measured during the intervention. CONCLUSIONS: A 12-week RTP improved MVIC and muscle power in MSpatients. Additionally, 12 weeks of detraining blunted strength training adaptations in MSpatients, although muscle power training adaptations were still evident after the detraining period.
Authors: Navina N Nasseri; Eghbal Ghezelbash; Yuyang Zhai; Stefan Patra; Karin Riemann-Lorenz; Christoph Heesen; Anne C Rahn; Jan-Patrick Stellmann Journal: PeerJ Date: 2020-06-23 Impact factor: 2.984
Authors: Ramon Gomez-Illan; Raul Reina; David Barbado; Rafael Sabido; Pedro Moreno-Navarro; Alba Roldan Journal: Medicina (Kaunas) Date: 2020-12-20 Impact factor: 2.430
Authors: Marit L Schlagheck; Niklas Joisten; Annette Rademacher; Philipp Zimmer; David Walzik; Florian Wolf; Sarah E Neil-Sztramko; Jens Bansi Journal: Neurol Ther Date: 2021-09-14
Authors: Kora Portilla-Cueto; Carlos Medina-Pérez; Ena Monserrat Romero-Pérez; Gabriel Núñez-Othón; Mario A Horta-Gim; José Antonio de Paz Journal: Medicina (Kaunas) Date: 2022-02-19 Impact factor: 2.430